SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000886163-13-000048
Filing Date
2013-06-04
Accepted
2013-06-04 17:04:30
Documents
3
Period of Report
2013-06-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ligandform8-kxproxystateme.htm 8-K 36288
2 PROXY SUPPLEMENT ligand2013proxysupplement.htm EX-99.1 239711
3 ligandlogo.jpg GRAPHIC 36525
  Complete submission text file 0000886163-13-000048.txt   327700
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 13892054
SIC: 2834 Pharmaceutical Preparations